Emefcy Microbial Fuel Cell Company Completes Series A Funding Round
CleanTech have reported that Emefcy, a microbial fuel cell startup based in Caesarea, Israel, has recently signed collaboration agreements with several potential clients. The companies will participate in Emefcy's pilot program in 2009 and will potentially have Emefcy's system installed in their plants in 2010, according to reports by the company.
Emefcy, co-founded by serial entrepreneurs Eytan Levy and Ronen Shechter, is developing the MEGAWATTER technology. This technology aims to produce low cost electricity (at $0.10/kWhr) and hydrogen in a bio-electro-chemical process from wastewater treatment by leveraging Microbial Fuel Cell (MFC) technology. Emefcy's technological breakthrough is focused on the development of electrode materials and structure that feature durability, high power output and low cost.
Levy and Shechter, who previously founded wastewater treatment company AqWise, have already received venture funding from Israel Cleantech Ventures, and Greentech Media has detailed Levy's efforts to raise $3.5-5.0m in a Series A funding round.
Emefcy's Scientific Advisory Board includes Prof. Bruce Logan of Pennsylvania State University, Prof. Derek Lovely of the University of Massachusetts (Amherst) and Prof. Bruce Rittmann, Director of the Biodesign Institute at the University of Arizona.
Source: Fuel Cell Today

